Elmar Kraus
Stock Analyst at DZ Bank
(1.85)
# 1,813
Out of 4,413 analysts
10
Total ratings
80%
Success rate
25.75%
Average return
Main Sectors:
Top Industries:
6 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly | Downgrades: Hold | $820 | $776.75 | +5.57% | 3 | Feb 21, 2024 | |
| GSK GSK | Downgrades: Hold | n/a | $42.57 | - | 1 | Feb 11, 2022 | |
| AZN AstraZeneca | Upgrades: Hold | n/a | $76.41 | - | 1 | Feb 11, 2022 | |
| PFE Pfizer | Upgrades: Buy | n/a | $27.18 | - | 1 | Feb 4, 2021 | |
| MDT Medtronic | Downgrades: Hold | n/a | $80.89 | - | 2 | May 14, 2020 | |
| GILD Gilead Sciences | Upgrades: Buy | n/a | $65.51 | - | 2 | Mar 18, 2020 |
Eli Lilly
Feb 21, 2024
Downgrades: Hold
Price Target: $820
Current: $776.75
Upside: +5.57%
GSK
Feb 11, 2022
Downgrades: Hold
Price Target: n/a
Current: $42.57
Upside: -
AstraZeneca
Feb 11, 2022
Upgrades: Hold
Price Target: n/a
Current: $76.41
Upside: -
Pfizer
Feb 4, 2021
Upgrades: Buy
Price Target: n/a
Current: $27.18
Upside: -
Medtronic
May 14, 2020
Downgrades: Hold
Price Target: n/a
Current: $80.89
Upside: -
Gilead Sciences
Mar 18, 2020
Upgrades: Buy
Price Target: n/a
Current: $65.51
Upside: -